Selected article for: "broad spectrum activity and spectrum activity"
Author: Nicola F Fletcher; Luke W Meredith; Emma L Tidswell; Steven R Bryden; Daniel Gonçalves-Carneiro; Yasmin Chaudhry; Claire Shannon-Lowe; Michael A Folan; Daniella A Lefteri; Marieke Pingen; Dalan Bailey; Clive S McKimmie; Alan W Baird
Title: A novel antiviral formulation inhibits a range of enveloped viruses.
  • Document date: 2020_3_30
    • ID: nly9vojr_82
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi. org/10.1101 org/10. /2020 transported across the respiratory epithelium to the lymphatic organs (Muhlebach et al., 2011) . Similarly, SARS-CoV-1 causes an acute interstitial pneumonia and was the causative agent of the 2002 SARS coronavirus epidemic. ViroSAL, therefore, has potential applications as a topical or inhaled therapy to treat epitheliotropic viral in.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi. org/10.1101 org/10. /2020 transported across the respiratory epithelium to the lymphatic organs (Muhlebach et al., 2011) . Similarly, SARS-CoV-1 causes an acute interstitial pneumonia and was the causative agent of the 2002 SARS coronavirus epidemic. ViroSAL, therefore, has potential applications as a topical or inhaled therapy to treat epitheliotropic viral infections or those that infect the airway or other mucous membranes. The fact that ViroSAL has applications against a wide range of enveloped viruses is of great interest, and while many antivirals have activity against specific viral families, there are few broad-spectrum antivirals currently available. Therefore, these data provide a rationale for future pre-clinical studies to investigate the antiviral properties of ViroSAL in viral infections of mucous membranes including the airway and skin.

    Search related documents:
    Co phrase search for related documents
    • acute interstitial pneumonia and causative agent: 1
    • acute interstitial pneumonia and interstitial pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute interstitial pneumonia and respiratory epithelium: 1
    • acute interstitial pneumonia and viral infection: 1, 2, 3
    • acute interstitial pneumonia and wide range: 1, 2, 3
    • acute interstitial pneumonia cause and interstitial pneumonia: 1, 2
    • antiviral property and broad spectrum: 1, 2, 3, 4, 5
    • antiviral property and broad spectrum antiviral: 1, 2, 3
    • antiviral property and great interest: 1
    • antiviral property and SARS coronavirus epidemic: 1
    • antiviral property and viral infection: 1, 2, 3
    • antiviral property and wide range: 1
    • broad spectrum and causative agent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • broad spectrum and great interest: 1, 2, 3, 4
    • broad spectrum and interstitial pneumonia: 1, 2, 3, 4, 5, 6
    • broad spectrum and mucous membrane: 1
    • broad spectrum and potential application: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • broad spectrum and respiratory epithelium: 1, 2, 3, 4
    • broad spectrum and SARS coronavirus epidemic: 1, 2, 3, 4, 5